Regulus Therapeutics
RGLS
#7200
Rank
โ‚น52.35 B
Marketcap
โ‚น756.19
Share price
0.00%
Change (1 day)
460.92%
Change (1 year)

EPS for Regulus Therapeutics (RGLS)

EPS in 2025 (TTM): -โ‚น61.75

According to Regulus Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น67.65. In 2024 the company made an earnings per share (EPS) of -โ‚น80.62.

EPS history for Regulus Therapeutics from 2013 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น61.75-23.4%
2024-โ‚น80.62
2022-โ‚น172.37-43.12%
2021-โ‚น303.03-40.55%
2020-โ‚น509.68-50%
2019-โ‚น1,019-80.36%
2018-โ‚น5,190-57.8%
2017-โ‚น12,297-28.66%
2016-โ‚น17,23742.2%
2015-โ‚น12,121-14.84%
2014-โ‚น14,234156%
2013-โ‚น5,560

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
โ‚น183.54-371.31%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
โ‚น218.70-423.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น418.87-719.18%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น659.81-1,075.34%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น266.64-494.16%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
-โ‚น35.21-47.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น1,836-2,813.70%๐Ÿ‡บ๐Ÿ‡ธ USA